Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for COPD Patients
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2016
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors AstraZeneca
- 26 Dec 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 11 Dec 2015 Planned End Date changed from 1 Nov 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.
- 11 Dec 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.